Drugs / Estradiol/Norethindrone acetate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01181726 | Jan → Feb 2007 | — | Teva Pharmaceuticals USA | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Estradiol/Norethindrone acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01181726 ↗ |
| Known as | Activella | “Activella® (1 mg estradiol/0.5 mg norethindrone acetate) Tablets” NCT01181726 ↗ |